Liminatus Pharma, Inc. (LIMN): Insider Trading, Congress Trades & Research | Tormere

LIMN

$2.79+10.71%visit website

Liminatus Pharma, Inc.

Market Cap

$187M

Live price × SEC shares (Aug 14, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

—

Insufficient price history

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

623.3

Mkt cap / shareholders' equity

Flagged input, hover for details

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development			400	600
Total operating expenses	701	884	1,101	1,379	4,065
Operating income	(701)	(884)	(1,101)	(1,379)	(4,065)
Interest expense	19.1	19.1	18.6	18.8	75.6
Net income	(1,823)	(8,169)	(1,124)	(1,407)	(12,523)
EPS (basic) ($)	(0.07)		(0.03)	(0.03)	—
EPS (diluted) ($)	(0.07)		(0.03)	(0.03)	—
Weighted avg. shares (basic)	27,008		36,000	48,398
Weighted avg. shares (diluted)	27,008		36,000	48,398

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 6 more quarters, back to Mar 2024, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

No Form 4 transactions on record.

Recent News

Liminatus Pharma, Inc. Estimates – NASDAQ:LIMN

TradingView · 2026-10-24

Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule

Yahoo Finance · 2026-09-29

Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy

Yahoo Finance · 2026-08-24

Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock

Yahoo Finance · 2026-08-18

Liminatus Pharma to implement 1-for-50 reverse stock split

Investing.com · 2026-08-18

Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement

Yahoo Finance · 2026-08-13

Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Bid Price Compliance

Quiver Quantitative · 2026-08-13

Thursday's session: most active stocks

ChartMill · 2026-07-02

Liminatus Pharma (LIMN) Stock Is Trending Overnight — Here’s Why it Spiked Over 30% in After-Hours Sessio

Benzinga · 2026-07-02

Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline

Yahoo Finance · 2026-06-30

Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds

Yahoo Finance · 2026-06-03

Liminatus Pharma Announces Nasdaq Delisting Notification

Yahoo Finance · 2026-05-22

Trending Stocks Today | Liminatus Pharma Surges 62.75%

Moomoo · 2026-05-21

Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody

Yahoo Finance · 2026-03-17

Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering

Yahoo Finance · 2026-02-17

Informational purposes only, not investment advice.